Therapeutic Advances in Endocrinology and Metabolism

SJR Rank #2,072H-index: 54SJR: 1.642Best quartile: Q1Open AccessAPC: US$2,650Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

Sage Periodicals Press

Country

United States

Type

journal

SJR by Edition

Subject Categories

Endocrinology, Diabetes and MetabolismQ1

Areas: Medicine

Most published research topics

Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsThyroid Disorders and TreatmentsPancreatic function and diabetesLiver Disease Diagnosis and TreatmentHyperglycemia and glycemic control in critically ill and hospitalized patientsThyroid Cancer Diagnosis and TreatmentDiabetes and associated disordersMetabolism, Diabetes, and Cancer

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

2042-0196, 2042-0188

SJR Best Quartile

Region

Northern America

Citations per Document (2 years)

7.47

References per Document

53.07

Coverage

2010-2026

Scope

Therapeutic Advances in Endocrinology and Metabolism delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of endocrine and metabolic conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in endocrinology, diabetic medicine and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of endocrinology and metabolic disease. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies - all phases. Letters to the Editor and Case Reports will also be considered.

Metrics from SCImago Journal Rank 2025. View on SCImago